August 1, 2015
Recommended Topic Related To:

Hylaform

"The U.S. Food and Drug Administration today approved the VenaSeal closure system (VenaSeal system) to permanently treat varicose veins of the legs by sealing the affected superficial veins using an adhesive agent.

There are two types of vei"...

Hylaform

PATIENT INFORMATION

It is recommended that the following information be shared with patients:

  • To report an adverse reaction, phone the Product Support Department, INAMED Corporation, (800) 624-4261.
  • Within the first 24 hours, patients should avoid:
    • Strenuous exercise
    • Extensive sun or heat exposure
    • Alcoholic beverages
      Exposure to any of the above may cause temporary redness, swelling, and/or itching at the injection sites.
  • Make-up may be applied a few hours post-treatment if no complications are present {e.g. open wounds, bleeding and infection).

Last reviewed on RxList: 7/11/2013
This monograph has been modified to include the generic and brand name in many instances.

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Women's Health

Find out what women really need.

Related Drugs
Use Pill Finder Find it Now See Interactions

Pill Identifier on RxList

  • quick, easy,
    pill identification

Find a Local Pharmacy

  • including 24 hour, pharmacies

Interaction Checker

  • Check potential drug interactions
Search the Medical Dictionary for Health Definitions & Medical Abbreviations